烟雾病治疗中国专家共识

2019-09-30 中国神经内科相关专家小组(统称) 国际脑血管病杂志.2019.27(9):645-650.

近年来,随着经颅多普勒超声、CT血管造影、磁共振血管造影以及数字减影血管造影等影像学技术的逐渐普及,烟雾病的确诊率逐年增高。由于病因不明,烟雾病尚无肯定有效的治疗药物,主要是针对缺血及出血症状进行对症处理.因此目前烟雾病的临床治疗仍然以颅内外血运重建手术为主。虽然我国现已有越来越多的医院开展烟雾病的手术治疗,但仍然缺乏统一的治疗规范。有鉴于此。本编写组共同商讨制订了关于烟雾病治疗的中国专家共识。

中文标题:

烟雾病治疗中国专家共识

发布日期:

2019-09-30

简要介绍:

近年来,随着经颅多普勒超声、CT血管造影、磁共振血管造影以及数字减影血管造影等影像学技术的逐渐普及,烟雾病的确诊率逐年增高。由于病因不明,烟雾病尚无肯定有效的治疗药物,主要是针对缺血及出血症状进行对症处理.因此目前烟雾病的临床治疗仍然以颅内外血运重建手术为主。虽然我国现已有越来越多的医院开展烟雾病的手术治疗,但仍然缺乏统一的治疗规范。有鉴于此。本编写组共同商讨制订了关于烟雾病治疗的中国专家共识。

 

拓展指南:烟雾病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=烟雾病治疗中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=5b6011c0018a643c, title=烟雾病治疗中国专家共识, enTitle=, guiderFrom=国际脑血管病杂志.2019.27(9):645-650., authorId=null, author=, summary=近年来,随着经颅多普勒超声、CT血管造影、磁共振血管造影以及数字减影血管造影等影像学技术的逐渐普及,烟雾病的确诊率逐年增高。由于病因不明,烟雾病尚无肯定有效的治疗药物,主要是针对缺血及出血症状进行对症处理.因此目前烟雾病的临床治疗仍然以颅内外血运重建手术为主。虽然我国现已有越来越多的医院开展烟雾病的手术治疗,但仍然缺乏统一的治疗规范。有鉴于此。本编写组共同商讨制订了关于烟雾病治疗的中国专家共识。 , cover=, journalId=null, articlesId=null, associationId=724, associationName=中国神经内科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Sep 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>近年来,随着经颅多普勒超声、CT血管造影、磁共振血管造影以及数字减影血管造影等影像学技术的逐渐普及,烟雾病的确诊率逐年增高。由于病因不明,烟雾病尚无肯定有效的治疗药物,主要是针对缺血及出血症状进行对症处理.因此目前烟雾病的临床治疗仍然以颅内外血运重建手术为主。虽然我国现已有越来越多的医院开展烟雾病的手术治疗,但仍然缺乏统一的治疗规范。有鉴于此。本编写组共同商讨制订了关于烟雾病治疗的中国专家共识。 </P> <P> </P>拓展指南:<strong>与<font color=red>烟雾病</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=6e8821c000906e0b" title="2012 日本烟雾病(Willis环自发性闭塞)诊断治疗指南" target=_blank>2012 日本烟雾病(Willis环自发性闭塞)诊断治疗指南</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%83%9F%E9%9B%BE%E7%97%85" target=_blank>有关烟雾病更多指南</a></ul>, tagList=[TagDto(tagId=7003, tagName=烟雾病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8012, appHits=609, showAppHits=8, pcHits=3691, showPcHits=6044, likes=91, shares=27, comments=9, approvalStatus=1, publishedTime=Mon Dec 30 23:33:23 CST 2019, publishedTimeString=2019-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Dec 30 23:33:23 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 23:00:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=烟雾病治疗中国专家共识)])
烟雾病治疗中国专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1064197, encodeId=66ce106419e3e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/0b51fdd098f2414c96406fc271734b62/44a705790a4b4e95883312ddbf3ab779.jpg, createdBy=fc012418521, createdName=江文涛, createdTime=Tue Oct 26 21:41:42 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962126, encodeId=33889621260f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:03:45 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969043, encodeId=919a969043ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4c5506374, createdName=ms4000000815144794, createdTime=Thu May 27 23:08:55 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962127, encodeId=3f9196212e6a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:04:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926404, encodeId=814392640460, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb55428452, createdName=ms6000000041248220, createdTime=Mon Feb 22 16:41:01 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-10-26 江文涛

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1064197, encodeId=66ce106419e3e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/0b51fdd098f2414c96406fc271734b62/44a705790a4b4e95883312ddbf3ab779.jpg, createdBy=fc012418521, createdName=江文涛, createdTime=Tue Oct 26 21:41:42 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962126, encodeId=33889621260f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:03:45 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969043, encodeId=919a969043ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4c5506374, createdName=ms4000000815144794, createdTime=Thu May 27 23:08:55 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962127, encodeId=3f9196212e6a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:04:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926404, encodeId=814392640460, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb55428452, createdName=ms6000000041248220, createdTime=Mon Feb 22 16:41:01 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-05-01 无优公子

    学习了

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1064197, encodeId=66ce106419e3e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/0b51fdd098f2414c96406fc271734b62/44a705790a4b4e95883312ddbf3ab779.jpg, createdBy=fc012418521, createdName=江文涛, createdTime=Tue Oct 26 21:41:42 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962126, encodeId=33889621260f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:03:45 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969043, encodeId=919a969043ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4c5506374, createdName=ms4000000815144794, createdTime=Thu May 27 23:08:55 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962127, encodeId=3f9196212e6a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:04:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926404, encodeId=814392640460, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb55428452, createdName=ms6000000041248220, createdTime=Mon Feb 22 16:41:01 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-05-27 ms4000000815144794

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1064197, encodeId=66ce106419e3e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/0b51fdd098f2414c96406fc271734b62/44a705790a4b4e95883312ddbf3ab779.jpg, createdBy=fc012418521, createdName=江文涛, createdTime=Tue Oct 26 21:41:42 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962126, encodeId=33889621260f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:03:45 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969043, encodeId=919a969043ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4c5506374, createdName=ms4000000815144794, createdTime=Thu May 27 23:08:55 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962127, encodeId=3f9196212e6a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:04:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926404, encodeId=814392640460, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb55428452, createdName=ms6000000041248220, createdTime=Mon Feb 22 16:41:01 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-05-01 无优公子

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1064197, encodeId=66ce106419e3e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/0b51fdd098f2414c96406fc271734b62/44a705790a4b4e95883312ddbf3ab779.jpg, createdBy=fc012418521, createdName=江文涛, createdTime=Tue Oct 26 21:41:42 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962126, encodeId=33889621260f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:03:45 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969043, encodeId=919a969043ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4c5506374, createdName=ms4000000815144794, createdTime=Thu May 27 23:08:55 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962127, encodeId=3f9196212e6a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210422/2a6d51bd31e04cb78008acb451b9440f/54e407fcffc541de86d8a63fa9d6c04d.jpg, createdBy=3ad35484138, createdName=无优公子, createdTime=Sat May 01 14:04:02 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926404, encodeId=814392640460, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb55428452, createdName=ms6000000041248220, createdTime=Mon Feb 22 16:41:01 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-02-22 ms6000000041248220

    学习了

    0